Skip to content
Subscriber Only

Takeda Ordered to Pay More Than $2 Million to Actos User

Takeda Pharmaceutical Co. was ordered by a jury to pay more than $2 million to a woman who claimed the company’s Actos diabetes medicine caused her bladder cancer, in the latest of thousands of lawsuits involving the drug to go to trial.

Jurors in state court in Philadelphia deliberated more than five hours today before finding that officials of Osaka, Japan-based Takeda failed to properly warn Frances Wisniewski’s doctors about Actos’s cancer risk.